COVID-19 Update - This is to inform you that the Government of India has announced a complete lockdown in India 22nd March 2020 to 3rd May 2020. As a result, our offices will now be closed till 3rd May 2020 and all our employees will be working from home. Office telephones will not be answered, and therefore you are requested to direct all your queries related to manuscript submission, review process, publication etc. at below mentioned details. editor@innovativepublication.com, rakesh.its@gmail.com, Mob. 8826373757, 8826859373, 9910947804

Article Access statistics

Viewed: 170

Emailed: 0

PDF Downloaded: 93

Journal of Pharmaceutical and Biological Sciences


Tablet scoring study of enalapril maleate tablets USP 20 mg


Full Text PDF Share on Facebook Share on Twitter


Research Article

Author Details : Ganesh B. Patil, Rajendra P. Marathe, Zamir G. Khan, Dilip A. Patil, Prashant B. Patil*

Volume : 7, Issue : 2, Year : 2019

Article Page : 50-55


Suggest article by email

Abstract

The present study of tablet scoring of Enalapril Maleate Tablets USP 20 mg it is necessary form FDA Guideline for Industry – Tablet Scoring: Nomenclature, Labeling and Data for Evaluation. These tablets scoring data described results are obtained during test performed on Enalapril Maleate Tablets USP 20 mg. The results are carrying out the test on exhibit batches. Various test are performed for these tablet scoring study like Loss of Mass on low, optimum or high speed (limit NMT 3%), Friability on low, optimum or high speed (limit NMT 1%), Dissolution is done by hand and splitter in 30 min., Content Uniformity is also done by hand or splitter limit is less than or equal to 15. Each and every parameter results are found within acceptable limit.

Keywords: Enalapril Maleate, Friability, Content Uniformity, Scoring.

Doi : 10.18231/j.jpbs.2019.009

How to cite : Patil G B, Marathe R P, Khan Z G, Patil D A, Patil P B, Tablet scoring study of enalapril maleate tablets USP 20 mg. J Pharm Biol Sci 2019;7(2):50-55

Copyright © 2019 by author(s) and J Pharm Biol Sci. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (CC-BY-NC 4.0) (creativecommons.org)